NCT01533194View on ClinicalTrials.gov

Viral Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Light Chain Deposition DiseaseRefractory Plasma Cell Myeloma
Interventions
OTHER

Diagnostic Laboratory Biomarker Analysis

Correlative studies

BIOLOGICAL

Wild-type Reovirus

Given IV

Trial Locations (1)

43210

Ohio State University Comprehensive Cancer Center, Columbus

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT01533194 - Viral Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma | Biotech Hunter | Biotech Hunter